Company profile: UroMed

1.1 - Company Overview

UroMed

Headquarter: United States

Founded: 20XX🔒

Employees: 100-500🔒

🌐 Website

Company description

Provider of urological and incontinence supplies; one of the largest providers in the nation; a Cardinal Health company.

Products and services

🔒

Key contacts

🔒

Financial details

🔒

1.2 - Competitors and similar companies to UroMed

Barrier Free Access

HQ: United States Website

Description: Provider of accessibility products and services enabling independent living for persons with disabilities and the elderly, as a division of a family-owned home remodeling construction company established in 1991, featuring an expanded showroom.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Barrier Free Access company profile →

J&B Medical

HQ: United States Website

Description: Provider of insurance-covered medical supplies—breast pumps, diabetes management products, and incontinence supplies—delivered to members’ homes with health plans and providers; medical and surgical supplies for professionals; supplies for emergency medical and fire teams; telehealth and remote patient monitoring via HNC Virtual Solutions; retail home healthcare through J&B At Home; and pet supplies, supplements, and pharmaceuticals via J&B Pet Source.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full J&B Medical company profile →

Freedom Medical

HQ: United States Website

Description: Provider of medical equipment and related services, serving hospitals and alternate-site healthcare providers across the United States and beyond, supported by knowledgeable, highly trained specialists.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Freedom Medical company profile →

Canadian Life Science

HQ: Canada Website

Description: Provider of chromatography, dissolution and spectroscopy products for Canadian laboratories and scientists, including HPLC columns, polymeric SPE, and brands for Partisil and Partishpere; serving the chromatography and spectroscopy industries since 1997 with thousands of high-quality products.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Canadian Life Science company profile →

Schaan Healthcare

HQ: Canada Website

Description: Provider of distribution services for medical and surgical supplies.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Schaan Healthcare company profile →

🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒

🔒 View all strategic buyers with complete profiles

Start Free Trial →

2.2 - Strategic buyer groups for UroMed

🔒

Buyer group 1: ████████ ████████

●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 2: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 3: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔓 Unlock all detailed buyer group breakdowns with complete company profiles

Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to UroMed

Buyout Funds
50+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US buyout funds investing in UroMed's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe buyout funds in UroMed's sector and industry vertical
View Funds →

2.2 - Growth funds investing in similar companies to UroMed

Growth Equity Funds
40+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US growth equity funds investing in UroMed's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe growth equity funds investing in UroMed's sector and industry vertical
View Funds →

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for UroMed

4.2 - Public trading comparable groups for UroMed

🔒

Comparable group 1: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 2: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 3: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to UroMed

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA

🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About UroMed

What does UroMed do?

UroMed is a provider of urological and incontinence supplies; one of the largest providers in the nation; a Cardinal Health company.

Who are UroMed's competitors?

UroMed's competitors and similar companies include Barrier Free Access, J&B Medical, Freedom Medical, Canadian Life Science, and Schaan Healthcare.

Where is UroMed headquartered?

UroMed is headquartered in United States.

How many employees does UroMed have?

UroMed has 1,000 employees 🔒.

When was UroMed founded?

UroMed was founded in 2010 🔒.

What sector and industry vertical is UroMed in?

UroMed is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for UroMed

Who are the top strategic acquirers in UroMed's sector and industry

Top strategic M&A buyers and acquirers in UroMed's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for UroMed?

Top strategic M&A buyers groups and sectors for UroMed include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in UroMed's sector and industry vertical

Which are the top PE firms investing in UroMed's sector and industry vertical?

Top PE firms investing in UroMed's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in UroMed's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in UroMed's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in UroMed's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to UroMed include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in UroMed's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for UroMed?

The key public trading comparables and valuation benchmarks for UroMed include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for UroMed for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for UroMed with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in UroMed's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for UroMed with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in UroMed's' sector and industry vertical?

Access recent funding rounds and capital raises in UroMed's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for UroMed

Start Free Trial Book a Demo